Functional and morphological effects of β-estradiol in eyes with N-methyl-d-Aspartate-induced retinal neurotoxicity in rats

Experimental Eye Research

Volumn 93, Issue 1, 2011, Pages 75-81

  Yamashita, Haruhiro ^a   Yamada Nakayama, Chiaki ^a   Sugihara, Kazunari ^a   Tsuji, Satoshi ^a   Sakurai, Takanobu ^a   Ban, Yoshiki ^a   Tsutsumi, Shunsuke ^a   Sato, Yasushi ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

estradiol; Full field ERG; N methyl d aspartate; Rat; Retinal neurotoxicity

Indexed keywords

ESTRADIOL; ISOFLURANE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; OXYBUPROCAINE; PHENYLEPHRINE; TROPICAMIDE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DRUG EFFECT; ELECTRORETINOGRAM; FUNCTIONAL MORPHOLOGY; MALE; NERVE CELL; NEUROTOXICITY; NONHUMAN; OSCILLATORY POTENTIAL; PRIORITY JOURNAL; RAT; RETINA DISEASE; RETINA INNER PLEXIFORM LAYER; VISUAL THRESHOLD;

ANIMALS; BODY WEIGHT; CELL COUNT; ELECTRORETINOGRAPHY; ESTRADIOL; ESTROGENS; EXCITATORY AMINO ACID AGONISTS; INTRAVITREAL INJECTIONS; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS;

EID: 79960377543     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.04.006     Document Type: Article

References (49)

1. Behl C., Manthey D. Neuroprotective activities of estrogen: an update. J. Neurocytol. 2000, 29:351-358.
2. Bringmann A., Uckermann O., Pannicke T., Iandiev I., Reichenbach A., Wiedemann P. Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol. Scand. 2005, 83:528-538.
3. Bui B.V., Fortune B. Ganglion cell contributions to the rat full-field electroretinogram. J. Physiol. 2003, 555:153-173.
4. Carrer H.F., Cambiasso M.J. Sexual differentiation of the brain: genes, estrogen, and neurotrophic factors. Cell. Mol. Neurobiol. 2002, 22:479-500.
5. Colotto A., Falsini B., Salgarello T., Iarossi G., Galan M.E., Scullica L. Photopic negative response of the human ERG: Losses associated with glaucomatous damage. Invest. Ophthalmol. Vis. Sci. 2000, 41:2205-2211.
6. Dai Y., Ou-Yang J., Chen X.-H., Wang X.-L. Effects of estrogen on retinal light injury. Int. J. Ophthalmol. 2008, 8:1165-1166.
7. Fang J.H., Wang X.H., Xu Z.R., Jiang F.G. Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage. BMC Neurosci. 2010, 11. art. no. 31.
8. Fletcher E.L., Hack I., Brandstätter J.H., Wässle H. Synaptic localization of NMDA receptor subunits in the rat retina. J. Comp. Neurol. 2000, 420:98-112.
9. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
10. Garcia-Valenzuela E., Shareef S., Walsh J., Sharma S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 1995, 61:33-44.
11. Hayashi Y., Kitaoka Y., Munemasa Y., Ohtani-Kaneko R., Kikusui T., Uematsu A., Takeda H., Hirata K., Mori Y., Ueno S. Neuroprotective effect of 17beta-estradiol against N-methyl-D-aspartate-induced retinal neurotoxicity via p-ERK induction. J. Neurosci. Res. 2007, 85:386-394.
12. Haan M.N., Klein R., Klein B.E., Deng Y., Blythe L.K., Seddon J.M., Musch D.C., Kuller L.H., Hyman L.G., Wallace R.B. Hormone therapy and age-related macular degeneration: the women's health initiative sight exam study. Arch. Ophthalmol. 2006, 124:988-992.
13. Honjo M., Tanihara H., Kido N., Inatani M., Okazaki K., Honda Y. Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA- and kainic acid-induced neuronal death. Invest. Ophthalmol. Vis. Sci. 2000, 41:552-560.
14. Kobayashi K., Kobayashi H., Ueda M., Honda Y. Estrogen receptor expression in bovine and rat retinas. Invest. Ophthalmol. Vis. Sci. 1998, 39:2105-2110.
15. Kooijman A.C., Damhof A. ERG lens with built-in Ganzfeld light source for stimulation and adaptation. Invest. Ophthalmol. Vis. Sci. 1980, 19:315-318.
16. Lam T.T., Siew E., Chu R., Tso M.O. Ameliorative effect of MK-801 on retinal ischemia. J. Ocul. Pharmacol. Ther. 1997, 13:129-137.
17. Lam T.T., Abler A.S., Kwong J.M.K., Tso M.O.M. N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest. Ophthalmol. Vis. Sci. 1999, 40:2391-2397.
18. Li B., Barnes G.E., Holt W.F. The decline of the photopic negative response (PhNR) in the rat after optic nerve transection. Doc. Ophthalmol. 2005, 111:23-31.
19. Li C., Tang Y., Li F., Turner S., Li K., Zhou X., Centola M., Yan X., Cao W. 17β-estradiol (βE2) protects human retinal Müller cell against oxidative stress in vitro: evaluation of its effects on gene expression by cDNA microarray. Glia 2006, 53:392-400.
20. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994, 330:613-622.
21. Liu C., Peng M., Laties A.M., Wen R. Preconditioning with bright light evokes a protective response against light damage in the rat retina. J. Neurosci. 1998, 18:1337-1344.
22. Louzada-Júnior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 1992, 59:358-363.
23. Maeda H. The origin of dark-adapted and light-adapted electroretinograms (ERGs) in the mouse. Folia Ophthalmol. Jpn 2007, 58:471-476.
24. Maruyama I., Maeda T., Okisaka S., Mizukawa A., Nakazawa M., Ohguro H. Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo. Jpn. J. Ophthalmol. 2002, 46:1-12.
25. Matsumoto A., Arai Y. Synaptogenic effect of estrogen on the hypothalamic arcuate nucleus of the adult female rat. Cell. Tissue Res. 1979, 198:427-433.
26. Matsumoto A., Arai Y. Neuronal plasticity in the deafferented hypothalamic arcuate nucleus of adult female rats and its enhancement by treatment with estrogen. J. Comp. Neurol. 1981, 197:197-205.
27. Mizuno K., Koide T., Yoshimura M., Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a β-blocker with nitric oxide donative action. Invest. Ophthalmol. Vis. Sci. 2001, 42:688-694.
28. Moosmann B., Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Inbestig. Drugs 2002, 11:1407-1435.
29. Morse J.K., Scheff S.W., DeKosky S.T. Gonadal steroids influence axon sprouting in the hippocampal dentate gyrus: a sexually dimorphic response. Exp. Neurol. 1986, 94:649-658.
30. Morse J.K., DeKosky S.T., Scheff S.W. Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. II. Hormone replacement. Exp. Neurol. 1992, 118:47-52.
31. Nakazawa T., Takahashi H., Shimura M. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Res. 2006, 1093:141-149.
32. Osborne N.N., Cazevieille C., Carvalho A.L., Larsen A.K., Desantis L. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res. 1997, 751:113-123.
33. Parsons C.G., Danysz W., Quack G. Glutamate in CNS disorders as a target for drug development: an update. Drug News Perspect. 1998, 11:523-569.
34. Russo R., Cavaliere F., Watanabe C., Nucci C., Bagetta G., Corasaniti M.T., Sakurada S., Morrone L.A. 17β-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog. Brain Res. 2008, 173:583-590.
35. Sauvé Y., Sawai H., Rasminsky M. Functional synaptic connections made by regenerated retinal ganglion cell axons in the superior colliculus of adult hamsters. J. Neurosci. 1995, 15:665-675.
36. Souza M.A., Geber S. Tibolone's effect on retinal and ophthalmic arteries flowmetry. Rev. Bras. Ginecol. Obstet 2008, 30:537-543.
37. Sperduto R.D., Yannuzzi L.A., Sorenson J.A., et al. Risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol. 1992, 110:1701-1708.
38. Sperduto R.D. Risk factors for central retinal vein occlusion the eye disease case-control study group. Arch. Ophthalmol. 1996, 114:545-554.
39. 2+ flux in mammalian central neurons. Neuroreport 1990, 1:29-32.
40. Sucher N.J., Aizenman E., Lipton S.A. N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J. Neurosci. 1991, 11:966-971.
41. Tanzer L., Jones K.J. Gonadal steroid regulation of hamster facial nerve regeneration: effects of dihydrotestosterone and estradiol. Exp. Neurol. 1997, 146:258-264.
42. Uckermann O., Vargová L., Ulbricht E., Klaus C., Weick M., Rillich K., Wiedemann P., Reichenbach A., Syková E., Bringmann A. Glutamate-evoked alterations of glial and neuronal cell morphology in the guinea pig retina. J. Neurosci. 2004, 24:10149-10158.
43. Viswanathan S., Frishman L.J., Robson J.G., Harwerth R.S., Smith E.L. The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma. Invest. Opthalmol. Vis. Sci. 1999, 40:1124-1136.
44. Wachtmeister L. Oscillatory potentials in the retina: what do they reveal. Prog. Retin. Eye Res. 1998, 17:485-521.
45. Yamashita H., Yamasaki K., Sugihara K., Miyata H., Tsutsumi S., Iwaki Y. Full-field electroretinography obtained using a contact lens electrode with built-in high-intensity white-light-emitting diodes can be utilized in toxicological assessments in rats. Ophthalmic Res. 2009, 42:15-20.
46. Yamashita H., Sugihara K., Yamada C., Tsutsumi S., Iwaki Y. Effect of estrogen on electroretinographic responses in streptozotocin-induced diabetic female rats. Exp. Eye Res. 2010, 90:591-597.
47. Yannuzzi L.A., Sorenson J.A., Sobel R.S., et al. Risk factors for idiopathic macular holes. Am. J. Optom. Physiol. Opt. 1994, 118:754-761.
48. Zaulyanov L.L., Green P.S., Simpkins J.W. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in vitro model for assessment of the neuroprotective effects of estrogens. Cell Mol. Neurobiol. 1999, 19:705-718.
49. Zhou X., Li F., Ge J., Sarkisian S.R., Tomita H., Zaharia A., Chodosh J., Cao W. Retinal ganglion cell protection by 17-β-estradiol in a mouse model of inherited glaucoma. Dev. Neurobiol. 2007, 67:603-616.